Search research articles
Contact Us
Filters
Showing results (131-140 of 297) with videos related to
Page
of 30
Sort By:
Arthritis Care & Research
|
July 12, 2021
Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis-Associated Interstitial Lung Disease
Monica M Yang, Lauren C Balmert, Roberta Goncalves Marangoni, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wenxia Wang, Swati Bhattacharyya, Roberta Goncalves Marangoni, et al.
The Journal of Investigative Dermatology
|
October 9, 2009
A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity
Jennifer L Sargent, Ausra Milano, Swati Bhattacharyya, et al.
Rheumatology (Oxford, England)
|
August 3, 2022
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups
Susan L Murphy, Yen T Chen, Yvonne C Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 22, 2025
Quantitative Digital Image Analysis for Assessing Cutaneous Fibrosis Correlates With Histopathological Scoring in Patients With Systemic Sclerosis
Ruben Oganesyan, Dimitra Pouli, Bo Shi, et al.
Plos One
|
September 21, 2011
Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis
Swati Bhattacharyya, Jennifer L Sargent, Pan Du, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2015
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling
Jun Wei, Archit K Ghosh, Haiyan Chu, et al.
Military Medicine
|
May 31, 2003
A descriptive analysis of hypertension and affiliated therapies in a military retiree population (ages 40-85 years) at Camp Lejeune, North Carolina
Bruce W Johnson, William G Davies, David W Hardy, et al.
JCI Insight
|
September 6, 2022
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma
Roberta G Marangoni, Poulami Datta, Ananta Paine, et al.
The Journal of Rheumatology
|
November 3, 2014
Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis
Monique E Hinchcliff, Jennifer L Beaumont, Mary A Carns, et al.
Page
of 30
Search research articles
Search
Showing results (131-140 of 297) with videos related to
Sort By:
Page
of 30
Arthritis Care & Research
|
July 12, 2021
Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis-Associated Interstitial Lung Disease
Monica M Yang, Lauren C Balmert, Roberta Goncalves Marangoni, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wenxia Wang, Swati Bhattacharyya, Roberta Goncalves Marangoni, et al.
The Journal of Investigative Dermatology
|
October 9, 2009
A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity
Jennifer L Sargent, Ausra Milano, Swati Bhattacharyya, et al.
Rheumatology (Oxford, England)
|
August 3, 2022
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups
Susan L Murphy, Yen T Chen, Yvonne C Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 22, 2025
Quantitative Digital Image Analysis for Assessing Cutaneous Fibrosis Correlates With Histopathological Scoring in Patients With Systemic Sclerosis
Ruben Oganesyan, Dimitra Pouli, Bo Shi, et al.
Plos One
|
September 21, 2011
Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis
Swati Bhattacharyya, Jennifer L Sargent, Pan Du, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2015
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling
Jun Wei, Archit K Ghosh, Haiyan Chu, et al.
Military Medicine
|
May 31, 2003
A descriptive analysis of hypertension and affiliated therapies in a military retiree population (ages 40-85 years) at Camp Lejeune, North Carolina
Bruce W Johnson, William G Davies, David W Hardy, et al.
JCI Insight
|
September 6, 2022
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma
Roberta G Marangoni, Poulami Datta, Ananta Paine, et al.
The Journal of Rheumatology
|
November 3, 2014
Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis
Monique E Hinchcliff, Jennifer L Beaumont, Mary A Carns, et al.
Page
of 30